Time

Event

8:00 am – Lobby Level

Registration Opens

8:00 am – Ground Floor,
Event Hall South

One-to-One Meetings 

8:55 am –  2nd Floor

Welcome Back 

• Sara Jane Demy, Founder & CEO, Demy-Colton 

9:00 am –  2nd Floor

“Big Think" Fireside Chat 

Rewriting the Narrative of Aging: Progress, Perspectives, and Future of Longevity Science and Healthspan 

Interviewer: Jeremy Abbate, Publisher, Scientific American

Interviewees:

• • Maria Torroella Carney, President, Glen Cove Hospital / Executive Director, Northwell Aging Institute / System Chief, Division of Geriatrics and Palliative Medicine, Northwell Health

  • Tim Opler, Managing Director, Global Healthcare Group, Stifel

10:00 am – Ground Floor,
Event Hall South

One-to-One Meetings 

10:00 am –  2nd Floor

Spotlight Panel 4A 

Molecules & Machine Learning: The AI Drug Discovery Frontier 

Moderator:

• Barbara Cheifet, Chief Editor Nature Biotechnology, Springer Nature

Panel:

• Edwin Addison, SVP, Finance & Business Development, QPMind

• Bogdan Knezevic, Co-Founder & CEO, Kaleidoscope.bio

• Akhila Kosaraju, CEO, Phare Bio

• Filipp Kramer, CEO, Alchemy Bio

10:00 am – 12th Floor

Spotlight Panel 4B 

Tomorrow, Today: Showcasing the Next Wave of Bio Breakthroughs

Moderator:

• David Schull, President, Russo Partners

Panel:

• Stacy Blain, CEO & Founder, Concarlo Therapeutics Inc.

• David Foster, CEO & Managing Director, Island Pharmaceuticals Ltd.

• David Pass, CEO, AltrixBio Inc.

• Bernard Peperstraete, Co-Founder & CEO, Acuamark Diagnostics, Inc.

• Michael Webb, CEO, Epion Therapeutics, Inc.

11:10 am – 2nd Floor

“Big Think” Plenary Session 

Dealmaking Dynamics: Navigating BD Strategies in a Competitive Biopharma Landscape 

Moderator:

• Arda Ural, Partner, Americas Sector Leader for Life Sciences, Ernst & Young LLP

Panel:  

• Warren Dunnavant, Managing Director, Investment Banking, H.C. Wainwright & Co., LLC

• Nouhad Husseini, Senior VP, BD & Corporate Strategy, Regeneron Pharmaceuticals, Inc.

• Konstantina Katcheves, Senior VP, Chief Business & Strategy Officer, Acadia Pharmaceuticals

12:00 pm – Ground Floor,
Event Hall South 

Lunch

1:15 pm – 2nd Floor

“Big Think" Plenary Session

The Price of Innovation: Navigating the Complex Landscape of Drug Pricing

Moderator:

• Peter Rubin, Executive Director, No Patient Left Behind

Panel:

• John Coster, Former Director, Division of Pharmacy, Center for Medicaid and CHIP Services, CMS; former Senior Technical Advisor for Medicare IRA Drug Rebate and Negotiation Group, Center for Medicare, CMS (invited)

• Neal Masia, Co-Founder & CEO, EntityRisk, Inc. 

• Brenda Wu, VP, Value & Access Strategy, Teva Pharmaceuticals

2:15 pm – Ground Floor,
Event Hall South

One-to-One Meetings

2:15 pm –  2nd Floor

Dialogue 2A 

New Developments in Cancer: Seeing the Signs 

Moderator: 

• Gregory Simon, Former Director, White House Cancer Moonshot

Panel:

• Bhavagaya Bakshi, CEO, C the Signs

• Roger Hajjar, Director, Gene and Cell Therapy Institute, Mass General Brigham

• Jeffrey Meckler, CEO, Indaptus Therapeutics

• Ashish Tripathi, CEO, Tzar Labs

2:15 pm –  12th Floor

Dialogue 2B 

Organoids: New Approach Methodologies 

Moderator:  

• Daniella Kranjac, Founding GP, Avant Bio

Panel:

• Daniel Delubac, CEO, iORGANBIO

• Julie Frearson, SVP & CSO, Charles River Laboratories

• Nicholas Geisse, CEO, Curi Bio, Inc.

• Alice Gilman, COO, R3 Biotechnologies 

• Luke Yu, SVP, Global Scientific Operations, Crown Bioscience

3:10 pm –  2nd Floor

Dialogue 3A 

The Immunome: Get Ready to Understand the Mother of All Systems 

Moderator:  

• David Ewing Duncan, Author, Journalist & Entrepreneur

Panel:

• Mike Fisher, Chief Commercial Officer, Oncimmune

• Rachel Sparks, Translational Medicine Physician, AstraZeneca; Research Affiliate, Yale University

• John Tsang, Anthony N. Brady Professor of Immunobiology and Biomedical Engineering, Yale University

3:10 pm – 12th Floor

Dialogue 3B 

Global Strategy in Transition: Opportunities and Risks in China 

Moderator:

• Michael D. Patten, Chief Strategy Officer, Harbour BioMed

Panel: 

• Raven Lin, CEO & Director, Pilatus Biosciences

• Tim Opler, Managing Director, Global Healthcare Group, Stifel

• Echo Hindle-Yang, Founder & CEO, MSQ Ventures

• Lihua Zheng, Co-Founder & CEO, Z-Star Therapeutics Inc.

4:10 pm – 2nd Floor

End of Day “Big Think" Plenary Session 

AI & Quantum Computing: Revolutionizing Healthcare                                    

Moderator:

• Beth Rogozinski, CEO, Oncoustics

Panel:

• Tala Fakhouri, VP Consulting, AI & Digital Policy, Real-World Research, Parexel

• Priyanka Rao, Investor, Rackhouse Venture Capital

• Rachel Ravens, Co-Founder & Managing Partner, 46Health

• MaryAnne Rizk, Managing Director, Head of Healthcare & Life Science Clinical Strategy, AWS

5:30-7:00 pm

Networking Reception

Barlume Downstairs – 900 Broadway (20th Street)
Sponsored by Russo Partners